05:39 AM EDT, 09/27/2024 (MT Newswires) -- (Updates with the stock move in the headline and the second paragraph.)

Establishment Labs Holdings ( ESTA ) said Thursday that the US Food and Drug Administration approved Motiva, SmoothSilk, Ergonomix, and Motiva SmoothSilk round breast implants in primary and revision breast augmentation.

Shares of Establishment Labs ( ESTA ) were up more than 29% in premarket activity Friday.

Motiva is the first new breast implant pre-market approval granted by the US FDA since 2013, according to the company.

Price: 51.05, Change: +12.17, Percent Change: +29.55